Cargando…
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole
Autores principales: | Crosby, L. D., Kalanidhi, S., Bonilla, A., Subramanian, A., Ballon, J. S., Bonilla, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860172/ https://www.ncbi.nlm.nih.gov/pubmed/33536023 http://dx.doi.org/10.1186/s12967-021-02721-9 |
Ejemplares similares
-
Publisher Correction to: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole
Publicado: (2021) -
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
por: Deumer, Undine-Sophie, et al.
Publicado: (2021) -
How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
por: Nacul, Luis, et al.
Publicado: (2020) -
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Günther, Oliver P., et al.
Publicado: (2018) -
The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Glassford, Julian A. G.
Publicado: (2017)